CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving the oral absorption of poorly soluble drugs by studying their solubilization in gastrointestinal fluids. It aims to develop a computational platform that predicts drug solubilization based on molecular interactions, enhancing drug development processes.
Improving the oral absorption of poorly water-soluble drug molecules remains one of the major challenges in the pharmaceutical industry. A key bottleneck in this process is the solubilization of administered lipophilic compounds in the small intestines, where bile salts (BS) and lipids assemble into colloidal particles.
Therefore, understanding the mechanisms and controlling factors of this process is critical for drug development.The advent of powerful supercomputers has enabled the integratio…
UNIVERSIDADE NOVA DE LISBOA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Beerse
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Netherlands, Groningen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
